Zurich (AWP) – The Swiss Stock Exchange began the trade from Friday in good shape, after finishing without clear direction the day before. In the same dynamic, the world’s places were invigorated by investors scrutinizing reductions in the coming rates of the American central bank (Fed).
“The United States and China have reached a commercial truce, the US administration said that 10 other agreements could be imminent, and the president of the European Commission has announced that she was ready to negotiate in order to reach an agreement before the deadline of July,” said Ipek Ozkardeskaya, analyst at Swissquote. “But overall, pricing uncertainties persist for key sectors such as metals, automotive and technology.”
At Wall Street, the enlarged S&P 500 index closed Thursday by winning 0.80%, at 6141.02 points. The NASDAQ technological index took 0.97% and the Dow Jones 0.94%.
European stock markets opened on Friday. Paris won 0.78%, Frankfurt 0.77%, London 0.36%, and Milan 0.52%.
Around 9:10 am, the SMI index gained 0.41% at 11,929.25 points, the SLI 0.7% at 1963.12 points, and the SPI 0.6% at 16,561.72 points. Of the 31 stars values, three appear red.
At the top of the ranking, Logitech advanced 2.3%, followed by ABB (+2.2%). The red lantern returned to Sandoz, Lindt and Swisscom (-0.1%). For the three heavy goods vehicles, Nestlé earned 0.7%, Novartis 0.4%and the good rock 0.1%.
The specialist in aromas and perfumes Givaudan (+0.6%) acquired majority participation in the Brazilian company Vollmens Fragrances. This acquisition should allow the Verniolan group to strengthen itself in the Latin American market, in rapid growth.
The SIKA construction chemist (+0.6%) announced on Friday the acquisition, for an undisclosed amount, of his Qatari Gulf Additive Factory counterpart. This operation allows the Zugoise firm to strengthen its presence in this Gulf country and to extend its presence in the region.
Excluding SMI, only Landis+Gyr fell 1.1%. Vat Group took the head of the SLI (+2.2%), and AMS OSRAM (+13.6%) enjoyed a positive comment from UBS.
The manufacturer of Ypsomed injection devices (+0.6%) puts its brand new factory into Changzhou, dedicated to exclusively supply the Empire in the middle, with a good semester of delay on the brushed roadmap in the spring of 2023.
ib/rr